Cheryl Guttman Krader
Antimicrobials approved for children’s skin infections
For the first time in a decade, there are antibiotics newly approved for use in children with skin and skin structure infections that do not respond to conventional treatment.
Learn to identify noncutaneous vascular anomalies
Education for pediatricians about vascular anomalies primarily focuses on cutaneous malformations and vascular tumors, but vascular anomalies also affect deeper tissues and organs.
Topical antibiotics and antiseptics disrupt the skin microbiome
Delayed diagnosis of PsA can lead to poor outcomes. Access to care elusive to some patients due to doctor shortage. Models of care that triage patients may shorten diagnostic delays
Sulzberger lecturer provides in-depth look at psoriasis comorbidities
In his talk at AAD 2017, Joel M. Gelfand, MD, MSCE, discussed the findings from research investigating associations between psoriasis and comorbidities and their relevance for providing comprehensive medical care for patients with psoriasis.
VMA associated with poor outcomes in anti-VEGF-treated patients
The presence of vitreomacular adhesion (VMA) is associated with poorer, short-term anatomic, and functional outcomes in eyes with diabetic macular edema (DME) receiving anti-VEGF therapy, according to Márcio B. Nehemy, MD, PhD.
Evolution in glaucoma surgery mounting with MIGS procedures
An expanding armamentarium of minimally invasive and micro-invasive glaucoma surgery procedures is transforming glaucoma management.
Home-monitoring devices offer better insight to figure out IOP
L. Jay Katz, MD. outlined the benefits of home IOP monitoring. These devices will offer a wealth of information that should lead to increased understanding of glaucoma and better patient care.
Micropulse probe transforms transscleral cyclophotocoagulation
Micropulse transscleral cyclophotocoagulation with a diode laser is demonstrating promising efficacy with better safety and tolerability than traditional TSCPC.
Novel drug delivery platforms: Filling a ‘GAP’ in glaucoma
Medical therapy for glaucoma is not becoming obsolete, but it is evolving away from conventional topical administration.
End-stage glaucoma requires outside-of-the-box management
Although the aim of glaucoma management is to maintain visual function, the role of the ophthalmologist does not end once a patient has lost useful vision. Robert L. Stamper, MD, discussed care for patients with end-stage glaucoma.
var script= ' ';